Home >> News >> Business >> Vascular Grafts Market To Reach Worth US$ 3,636.9 Mn By 2025

Vascular Grafts Market To Reach Worth US$ 3,636.9 Mn By 2025

The purpose of the report is to illustrate the state of the market of Vascular Grafts, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.

Browse here for full report: https://www.credenceresearch.com/report/vascular-grafts-market

Market Insights

Vascular grafts are touted as one of the most common prosthetics used in vascular and cardiovascular surgeries worldwide due to their proven and established ability to improve vascular access. Rising prevalence of CVDs such as cardiac aneurysms, hypertension, and coronary diseases and other vascular conditions such as end stage renal diseases, diabetes and other factors significantly attribute to the growth of vascular grafts market. Among these, coronary artery disease is one of the most commonly prevalent conditions worldwide and its treatment largely contributes to the demand for vascular grafts.

Based on types, the global vascular grafts market is studied for endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts and coronary artery by-pass grafts. Among these, endovascular grafts form the largest segment, capturing over 80% revenue share in 2016. Major factors contributing to the dominance of this segment are rise in prevalence of vascular disorders on the ground of inappropriate diet, sedentary lifestyle, and possible hereditary influence. Growing prevalence of hypertension, high blood sugar levels, and other risk factors lead to arterial blockage, contributing to increased prevalence of renal and cardiac diseases, thus touting increased demand for endovascular stent grafts.

Among the various materials used for vascular grafts, synthetic based grafts hold the largest market share in the global market. Higher tensile strength, curability, cheaper cost and easy availability are the key factors that contribute to high demand for synthetic vascular grafts. However, it is estimated that the demand for biological vascular stents will be the fastest during the forecast period. Enhanced biocompatibility, and technological advancement are the key factors attributed to growing demand for biological vascular grafts.

Vascular stents are majorly used for treating cardiovascular diseases, aneurysm, kidney failure, vascular occlusion and diabetes. Among the considered diseases, the demand for vascular stents for treating cardiovascular conditions is observed to be the highest and it is anticipated that the trends will continue through the forecast period. The overall cardiovascular implants market (stents and grafts) is rapidly growing due to escalation in the number of patients with cardiovascular diseases and restrained availability of biological options. Therefore, the demand for synthetic implants for cardiovascular treatments as these are often off-the-shelf products and offer a wide range of design specifications.

Geographically, North America is the current leader in the global vascular stents market with a revenue share of over 40% (2016). Existence of developed healthcare system, and rising prevalence of CVDs in the region are the major attributes of the dominant status of North America on the global front. Domicile of market incumbents in the region that are increasing their research efforts towards introducing novel products has additionally led to swift adoption of latest products in North America. On the other hand, Asia Pacific is observed to be the fastest growing market for vascular grafts. Increase in high risk geriatric population, rapid penetration of major market players in the region and growing chronic disease prevalence majorly contribute to the rapid growth of Asia Pacific market.

The global vascular grafts is highly fragmented and is characterized by the presence of both large established players and smaller regional or local companies. However, only a limited group of companies together hold a considerable revenue share in the market. players such as MAQUET Holding B.V. & Co. KG, B. Braun Melsungen AG, C.R. Bard, Cook Medical, Inc. and a few more are considered as incumbents in the global market.

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Vascular Grafts buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Vascular Grafts contains:

Analysis and forecast of Vascular Grafts market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Vascular Grafts market;

Assessment and forecast of Vascular Grafts market development;

Financial and business profiles of the leading companies in the Vascular Grafts industry.

Scope

– Up to date working Vascular Grafts data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Vascular Grafts for the period 2018 to 2026

– Planned Vascular Grafts additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Vascular Grafts projects by region, key countries, and companies

– Details of major planned Vascular Grafts projects in the world up to 2026

Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58546

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *